295 related articles for article (PubMed ID: 30295993)
1. A comparative study of resveratrol and resveratrol-functional selenium nanoparticles: Inhibiting amyloid β aggregation and reactive oxygen species formation properties.
Yang L; Wang W; Chen J; Wang N; Zheng G
J Biomed Mater Res A; 2018 Dec; 106(12):3034-3041. PubMed ID: 30295993
[TBL] [Abstract][Full Text] [Related]
2. Oral Administration of Resveratrol-Selenium-Peptide Nanocomposites Alleviates Alzheimer's Disease-like Pathogenesis by Inhibiting Aβ Aggregation and Regulating Gut Microbiota.
Li C; Wang N; Zheng G; Yang L
ACS Appl Mater Interfaces; 2021 Oct; 13(39):46406-46420. PubMed ID: 34569225
[TBL] [Abstract][Full Text] [Related]
3. Ability of selenium species to inhibit metal-induced Aβ aggregation involved in the development of Alzheimer's disease.
Vicente-Zurdo D; Romero-Sánchez I; Rosales-Conrado N; León-González ME; Madrid Y
Anal Bioanal Chem; 2020 Sep; 412(24):6485-6497. PubMed ID: 32322953
[TBL] [Abstract][Full Text] [Related]
4. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Effect of Combining Chlorogenic Acid on Selenium Nanoparticles in Inhibiting Amyloid β Aggregation and Reactive Oxygen Species Formation In Vitro.
Yang L; Wang N; Zheng G
Nanoscale Res Lett; 2018 Sep; 13(1):303. PubMed ID: 30269259
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol-loaded selenium/chitosan nano-flowers alleviate glucolipid metabolism disorder-associated cognitive impairment in Alzheimer's disease.
Yang L; Wang Y; Zheng G; Li Z; Mei J
Int J Biol Macromol; 2023 Jun; 239():124316. PubMed ID: 37004937
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol-Selenium Nanoparticles Alleviate Neuroinflammation and Neurotoxicity in a Rat Model of Alzheimer's Disease by Regulating Sirt1/miRNA-134/GSK3β Expression.
Abozaid OAR; Sallam MW; El-Sonbaty S; Aziza S; Emad B; Ahmed ESA
Biol Trace Elem Res; 2022 Dec; 200(12):5104-5114. PubMed ID: 35059981
[TBL] [Abstract][Full Text] [Related]
8. Light-Induced Chiral Iron Copper Selenide Nanoparticles Prevent β-Amyloidopathy In Vivo.
Zhang H; Hao C; Qu A; Sun M; Xu L; Xu C; Kuang H
Angew Chem Int Ed Engl; 2020 Apr; 59(18):7131-7138. PubMed ID: 32067302
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective activity of selenium nanoparticles against the effect of amino acid enantiomers in Alzheimer's disease.
Vicente-Zurdo D; Rodríguez-Blázquez S; Gómez-Mejía E; Rosales-Conrado N; León-González ME; Madrid Y
Anal Bioanal Chem; 2022 Nov; 414(26):7573-7584. PubMed ID: 35982253
[TBL] [Abstract][Full Text] [Related]
10. Conjugation of RTHLVFFARK to human lysozyme creates a potent multifunctional modulator for Cu
Li X; Wang W; Dong X; Sun Y
J Mater Chem B; 2020 Mar; 8(11):2256-2268. PubMed ID: 32100783
[TBL] [Abstract][Full Text] [Related]
11. d-Enantiomeric RTHLVFFARK-NH
Liu W; Dong X; Sun Y
ACS Chem Neurosci; 2019 Mar; 10(3):1390-1401. PubMed ID: 30650306
[TBL] [Abstract][Full Text] [Related]
12. Functionalized Cerium Dioxide Nanoparticles with Antioxidative Neuroprotection for Alzheimer's Disease.
Hu Y; Guo H; Cheng S; Sun J; Du J; Liu X; Xiong Y; Chen L; Liu C; Wu C; Tian H
Int J Nanomedicine; 2023; 18():6797-6812. PubMed ID: 38026525
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol-maltol hybrids as multi-target-directed agents for Alzheimer's disease.
Cheng G; Xu P; Zhang M; Chen J; Sheng R; Ma Y
Bioorg Med Chem; 2018 Dec; 26(22):5759-5765. PubMed ID: 30360953
[TBL] [Abstract][Full Text] [Related]
14. Phycocyanin-Functionalized Selenium Nanoparticles Reverse Palmitic Acid-Induced Pancreatic β Cell Apoptosis by Enhancing Cellular Uptake and Blocking Reactive Oxygen Species (ROS)-Mediated Mitochondria Dysfunction.
Liu C; Fu Y; Li CE; Chen T; Li X
J Agric Food Chem; 2017 Jun; 65(22):4405-4413. PubMed ID: 28510423
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of resveratrol and EGCG in the inhibition of Aβ
Li F; Zhan C; Dong X; Wei G
Phys Chem Chem Phys; 2021 Sep; 23(34):18843-18854. PubMed ID: 34612422
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of imine resveratrol derivatives as multi-targeted agents against Alzheimer's disease.
Li SY; Wang XB; Kong LY
Eur J Med Chem; 2014 Jan; 71():36-45. PubMed ID: 24269515
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and evaluation of Trolox-conjugated amyloid-β C-terminal peptides for therapeutic intervention in an in vitro model of Alzheimer's disease.
Arai T; Ohno A; Kazunori M; Kakizawa T; Kuwata H; Ozawa T; Shibanuma M; Hara S; Ishida S; Kurihara M; Miyata N; Nakagawa H; Fukuhara K
Bioorg Med Chem; 2016 Sep; 24(18):4138-4143. PubMed ID: 27407032
[TBL] [Abstract][Full Text] [Related]
18. Progressive release of mesoporous nano-selenium delivery system for the multi-channel synergistic treatment of Alzheimer's disease.
Sun J; Wei C; Liu Y; Xie W; Xu M; Zhou H; Liu J
Biomaterials; 2019 Mar; 197():417-431. PubMed ID: 30638753
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol-mediated cleavage of amyloid β
Al-Edresi S; Alsalahat I; Freeman S; Aojula H; Penny J
Neurobiol Aging; 2020 Oct; 94():24-33. PubMed ID: 32512325
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of amyloid-β aggregation in Alzheimer's disease.
Wang Q; Yu X; Li L; Zheng J
Curr Pharm Des; 2014; 20(8):1223-43. PubMed ID: 23713775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
